18
Participants
Start Date
April 25, 2025
Primary Completion Date
April 1, 2028
Study Completion Date
April 1, 2028
anti-BCMA/CD70-CAR-T cells
Three dose groups (0.3×105/kg, 1×105/kg, 3×105/kg) were set up, starting from the low dose group climbing to explore the safe and effective dose.
RECRUITING
hildren's Hospital of Zhejiang University School of Medicine, Hangzhou
Chongqing Precision Biotech Co., Ltd
INDUSTRY
The Children's Hospital of Zhejiang University School of Medicine
OTHER